default author photo

James S. O. McCullagh

University of Oxford - Department of Chemistry

Oxford , OX1 3QR

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

263

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

An Accessible, Low-Cost Tool Using Artificial Intelligence for Dried Spot Analysis to Identify Falsified Vaccines and Other Liquid Medicines

Number of pages: 32 Posted: 25 Nov 2024
Datamarkin, University of Oxford - Department of Biochemistry, University of Oxford - Department of Biochemistry, University of Oxford - Department of Chemistry, University of Oxford - Department of Biochemistry, University of Oxford - Department of Chemistry, Nuffield Department of Medicine - Centre for Tropical Medicine & Global Health, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, Rutherford Appleton Laboratory - Research Complex at Harwell, Rutherford Appleton Laboratory - Research Complex at Harwell, Rutherford Appleton Laboratory - Research Complex at Harwell, Agilent Technologies LDA UK, Mahidol University - Mahidol-Oxford Tropical Medicine Research Unit, University of East London, Nuffield Department of Medicine - Centre for Tropical Medicine & Global Health, University of Oxford - Department of Chemistry, Nuffield Department of Medicine - Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine - Centre for Tropical Medicine & Global Health, University of Oxford - Department of Biochemistry and University of Oxford - Department of Biochemistry
Downloads 143 (514,995)
Citation 1

Abstract:

Loading...

falsified medicines, vaccines, insulin, Artificial Intelligence

2.

Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID Pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics

Number of pages: 48 Posted: 08 Nov 2021
University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, NHS Lothian - Regional Infectious Disease Unit, NHS Lothian - Regional Infectious Disease Unit, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, Government of the United Kingdom - NHS Greater Glasgow and Clyde, Government of the United Kingdom - Department of Respiratory Medicine, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Royal Infirmary of Edinburgh, NHS Lothian - Regional Infectious Disease Unit, NHS Lothian - Regional Infectious Disease Unit, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Royal Infirmary of Edinburgh, Latus Therapeutics, University of Oxford - Department of Pharmacology, University of Oxford - Department of Chemistry, King’s College London - Institute of Pharmaceutical Science, Government of the United Kingdom - Department of Radiology, Royal Infirmary of Edinburgh - Department of Medical Microbiology, University of Liverpool - Centre of Excellence for Long-acting Therapeutics, University of Liverpool - Centre of Excellence for Long-acting Therapeutics, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Edinburgh Clinical Trials Unit (ECTU), University of Edinburgh - Edinburgh Clinical Trials Unit (ECTU), University of Edinburgh - Centre for Inflammation Research, University of Oxford - Department of Pharmacology, University of Edinburgh - University/British Heart Foundation Centre of Research Excellence, University of Edinburgh - Centre for Inflammation Research and University of Edinburgh - Royal Infirmary of Edinburgh
Downloads 85 (771,553)

Abstract:

Loading...

Respiratory Medicine 
Infectious Diseases

3.

Cone Photoreceptor Phosphodiesterase 6H Inhibition Regulates Cancer Cell Growth and Metabolism Replicating the Dark Retina Response

Number of pages: 46 Posted: 27 Apr 2022
University of Oxford - Department of Oncology, University of Oxford - Hypoxia and Angiogenesis Group, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oxford, affiliation not provided to SSRN, University of Oxford - Department of Chemistry and University of Oxford - Hypoxia and Angiogenesis Group
Downloads 35 (1,249,711)

Abstract:

Loading...